Photocure ASA 2020 SR
The report highlights Photocure's commitment to improving the lives of bladder cancer patients through its photodynamic technology. In 2020, the company navigated the COVID-19 pandemic while expanding its global reach and regaining commercialization rights for Hexvix in Europe. Key focus areas included product quality and safety, supply chain responsibility, and business ethics, including the establishment of a compliance program and an anonymous whistleblowing channel. The company also reported on its workforce diversity, with women making up 40% of the board and 63% of senior management.
Company: Photocure ASA
Sector: Manufacturing
Country: Norway
Year: 2020
Type: SR
Pages: 11
Back to company
Photocure ASA
ESG Report
The report highlights Photocure's commitment to improving the lives of bladder cancer patients through its photodynamic technology. In 2020, the company navigated the COVID-19 pandemic while expanding its global reach and regaining commercialization rights for Hexvix in Europe. Key focus areas included product quality and safety, supply chain responsibility, and business ethics, including the establishment of a compliance program and an anonymous whistleblowing channel. The company also reported on its workforce diversity, with women making up 40% of the board and 63% of senior management.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees